Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Kerr

Showing results (41-50 of 218) with videos related to

Pageof 22
Sort By:
Seminars in Dialysis|March 25, 2010
A rational guide to reducing fracture risk in dialysis patientsNigel D Toussaint, Grahame J Elder, Peter G Kerr
BMC Nephrology|April 4, 2019
A need-based approach to self-management education for adults with co-morbid diabetes and chronic kidney diseaseEdward Zimbudzi, Clement Lo, Peter G Kerr, et al.
Seminars in Dialysis|November 24, 2011
Home hemodialysis in Australia and New Zealand: how and why it has been successfulJohn W M Agar, Carmel M Hawley, Peter G Kerr
Seminars in Dialysis|November 24, 2011
Alternate night nocturnal hemodialysis: the Australian experiencePeter G Kerr, John W M Agar, Carmel M Hawley
ANZ Journal of Surgery|June 20, 2002
Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporinPornpen Sangthawan, Jane Fox, Robert C Atkins, et al.
Nephrology (Carlton, Vic.)|February 16, 2008
The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetesSophia Zoungas, Peter G Kerr, Michelle Lui, et al.
The Medical Journal of Australia|January 22, 2008
Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathyAndy K H Lim, David H Hooke, Peter G Kerr
Nephrology (Carlton, Vic.)|April 18, 2018
Use of deferasirox (Exjade) for iron overload in peritoneal dialysis patientsErwin Yii, James Cg Doery, Zane Kaplan, et al.
Nephrology (Carlton, Vic.)|February 23, 2022
A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea-190H) to a standard high flux polysulfone dialyser membrane (FX-80) in the setting of extended hours haemodialysisKamya Kameshwar, Matthew J Damasiewicz, Kevan R Polkinghorne, et al.
Nephrology (Carlton, Vic.)|September 3, 2008
Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?Dibya S Shah, Kevan R Polkinghorne, Rebecca Pellicano, et al.
Pageof 22

Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
Seminars in Dialysis|March 25, 2010
A rational guide to reducing fracture risk in dialysis patientsNigel D Toussaint, Grahame J Elder, Peter G Kerr
BMC Nephrology|April 4, 2019
A need-based approach to self-management education for adults with co-morbid diabetes and chronic kidney diseaseEdward Zimbudzi, Clement Lo, Peter G Kerr, et al.
Seminars in Dialysis|November 24, 2011
Home hemodialysis in Australia and New Zealand: how and why it has been successfulJohn W M Agar, Carmel M Hawley, Peter G Kerr
Seminars in Dialysis|November 24, 2011
Alternate night nocturnal hemodialysis: the Australian experiencePeter G Kerr, John W M Agar, Carmel M Hawley
ANZ Journal of Surgery|June 20, 2002
Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporinPornpen Sangthawan, Jane Fox, Robert C Atkins, et al.
Nephrology (Carlton, Vic.)|February 16, 2008
The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetesSophia Zoungas, Peter G Kerr, Michelle Lui, et al.
The Medical Journal of Australia|January 22, 2008
Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathyAndy K H Lim, David H Hooke, Peter G Kerr
Nephrology (Carlton, Vic.)|April 18, 2018
Use of deferasirox (Exjade) for iron overload in peritoneal dialysis patientsErwin Yii, James Cg Doery, Zane Kaplan, et al.
Nephrology (Carlton, Vic.)|February 23, 2022
A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea-190H) to a standard high flux polysulfone dialyser membrane (FX-80) in the setting of extended hours haemodialysisKamya Kameshwar, Matthew J Damasiewicz, Kevan R Polkinghorne, et al.
Nephrology (Carlton, Vic.)|September 3, 2008
Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?Dibya S Shah, Kevan R Polkinghorne, Rebecca Pellicano, et al.
Pageof 22